Heron Therapeutics Inc (HRTX)

05:03 AM

Brokers Offer Predictions for HRTX Q1 Earnings - Defense World

05:03 AM

02:30 AM

Heron Therapeutics’ (HRTX) Buy Rating Reiterated at Needham & Company LLC - Defense World

02:30 AM

Mar 02, 2025

D.A. Davidson & CO. Has $57,000 Position in Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat

Mar 02, 2025

Mar 02, 2025

Heron Therapeutics, Inc. (NASDAQ:HRTX) Just Reported Earnings, And Analysts Cut Their Target Price - Yahoo Finance

Mar 02, 2025

Mar 02, 2025

Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Purchased by New York State Common Retirement Fund - Defense World

Mar 02, 2025

Mar 02, 2025

Heron Therapeutics (NASDAQ:HRTX) Stock Rating Upgraded by StockNews.com - Defense World

Mar 02, 2025

Mar 01, 2025

Heron Therapeutics (NASDAQ:HRTX) Upgraded to Buy at StockNews.com - MarketBeat

Mar 01, 2025

Mar 01, 2025

Heron Therapeutics' (HRTX) "Buy" Rating Reaffirmed at Needham & Company LLC - MarketBeat

Mar 01, 2025

Mar 01, 2025

Heron Therapeutics, Inc.'s (NASDAQ:HRTX) Shares Bounce 48% But Its Business Still Trails The Industry - Simply Wall St

Mar 01, 2025

Feb 28, 2025

Heron Therapeutics (NASDAQ:HRTX) Issues Earnings Results, Beats Expectations By $0.05 EPS - MarketBeat

Feb 28, 2025

Feb 28, 2025

Heron Therapeutics (NASDAQ:HRTX) Announces Quarterly Earnings Results, Beats Estimates By $0.05 EPS - MarketBeat

Feb 28, 2025

Feb 28, 2025

Heron Therapeutics, Inc. (NASDAQ:HRTX) Q4 2024 Earnings Call Transcript - Insider Monkey

Feb 28, 2025

Feb 28, 2025

High Growth Tech Stocks to Watch in US Market February 2025 - Yahoo Finance

Feb 28, 2025

Feb 28, 2025

Heron Therapeutics (NASDAQ:HRTX) shareholders are up 19% this past week, but still in the red over the last five years - Simply Wall St

Feb 28, 2025

Feb 28, 2025

Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Sold by D.A. Davidson & CO. - Defense World

Feb 28, 2025

Feb 27, 2025

Heron Therapeutics Reports Strong 2024 Financial Results - TipRanks

Feb 27, 2025

Feb 27, 2025

Heron Therapeutics Inc. Reports Strong Earnings and Strategic Growth - TipRanks

Feb 27, 2025

Feb 27, 2025

Earnings call transcript: Heron Therapeutics Q4 2024 beats EPS forecast, stock surges - Investing.com Canada

Feb 27, 2025

Feb 27, 2025

Heron Therapeutics: Q4 Earnings Snapshot - CT Insider

Feb 27, 2025

Feb 27, 2025

Heron Therapeutics stock soars 21% on earnings beat, strong guidance - Investing.com

Feb 27, 2025

Feb 27, 2025

Heron Therapeutics stock soars 21% on earnings beat, strong guidance By Investing.com - Investing.com Australia

Feb 27, 2025

Feb 27, 2025

Heron Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com

Feb 27, 2025

Feb 27, 2025

Heron Therapeutics (HRTX) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance

Feb 27, 2025

Feb 27, 2025

HERON THERAPEUTICS Earnings Results: $HRTX Reports Quarterly Earnings - Nasdaq

Feb 27, 2025

Feb 27, 2025

Heron Therapeutics Announces Fourth Quarter and Full-Year 2024 Financial Results - TradingView

Feb 27, 2025

Feb 27, 2025

HERON THERAPEUTICS, INC. /DE/ SEC 10-K Report - TradingView

Feb 27, 2025

Feb 27, 2025

Heron Therapeutics Announces Fourth Quarter and Full-Year 2024 Financial Results and Highlights Recent Corporate Updates - PR Newswire

Feb 27, 2025

Feb 25, 2025

Heron Therapeutics (HRTX) Expected to Announce Earnings on Thursday - MarketBeat

Feb 25, 2025

Feb 21, 2025

Heron Therapeutics (HRTX) to Release Quarterly Earnings on Thursday - Defense World

Feb 21, 2025

Feb 20, 2025

Heron Therapeutics Amends Working Capital Facility Agreement -February 20, 2025 at 03:23 pm EST - Marketscreener.com

Feb 20, 2025

Feb 20, 2025

Heron Therapeutics extends loan agreement maturity to 2027 - Investing.com

Feb 20, 2025

Feb 20, 2025

Heron Therapeutics extends loan agreement maturity to 2027 By Investing.com - Investing.com UK

Feb 20, 2025

Feb 19, 2025

Ratios in Focus: Analyzing Heron Therapeutics Inc (HRTX)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Feb 19, 2025

Feb 18, 2025

Heron Therapeutics (NASDAQ:HRTX) Share Price Passes Above 200 Day Moving AverageTime to Sell? - MarketBeat

Feb 18, 2025

Feb 15, 2025

Heron Therapeutics (NASDAQ:HRTX) Stock Price Passes Above Two Hundred Day Moving Average – Should You Sell? - Defense World

Feb 15, 2025

Feb 13, 2025

Heron Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results On Thursday, February 27, 2025 - StreetInsider.com

Feb 13, 2025

Feb 13, 2025

Accomplished CEO eyes another success story in Cary - The Business Journals

Feb 13, 2025

Feb 10, 2025

Analysts review Heron Therapeutics Inc’s rating - Knox Daily

Feb 10, 2025

Feb 10, 2025

Heron Therapeutics (NASDAQ:HRTX) Stock Crosses Above 200 Day Moving AverageShould You Sell? - MarketBeat

Feb 10, 2025

Feb 06, 2025

An analyst sees good growth prospects for Heron Therapeutics Inc (HRTX) - SETE News

Feb 06, 2025

Feb 04, 2025

Financial Metrics Check: Heron Therapeutics Inc (HRTX)’s Ratios for Trailing Twelve Months - The Dwinnex

Feb 04, 2025

Feb 04, 2025

Are Heron Therapeutics Inc (HRTX) shares a good deal now? - US Post News

Feb 04, 2025

Feb 02, 2025

Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Purchased by JPMorgan Chase & Co. - MarketBeat

Feb 02, 2025

Feb 01, 2025

StockNews.com Downgrades Heron Therapeutics (NASDAQ:HRTX) to Hold - MarketBeat

Feb 01, 2025

Jan 30, 2025

JPMorgan Chase & Co. Has $411,000 Stake in Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World

Jan 30, 2025